Canagliflozin reduces the risk for cardiovascular and...
Artículos Científicos en Ingles
Artículos Científicos RSS AJKD
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program | Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United StatesUnderlying kidney disease is an emerging risk factor for... | Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney InjuryOutcomes of patients hospitalized with coronavirus... |
Antigens in Membranous Nephropathy: Progress Toward PrecisionMembranous nephropathy (MN) is an autoimmune glomerular... | Hypertension Management in Patients With Autosomal Dominant Polycystic Kidney Disease: Time for a Paradigm Shift?In the study by Cho et al,1 blood pressure (BP)... |


